Qianglian Zhichuang is the first high-tech company in China to focus on the pain points of cerebrovascular disease treatment.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Beijing
State: Beijing
Zip:
Country: China
the first high-tech company in China to focus on the treatment of cerebrovascular disease, it has more than four years of product research and development, leading China&s;s cerebrovascular disease intelligence in an all-around way. vertical field of diagnosis and treatment. It has become a well-known brain stroke intelligence diagnosis and treatment platform in China.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2022 | Series C | 2 | $15.7M |
Poly Capital Sequoia Capital China Poly Capital Sequoia Capital China |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|